PT1372652E - Combinação de docetaxel e flavopiridol - Google Patents

Combinação de docetaxel e flavopiridol Download PDF

Info

Publication number
PT1372652E
PT1372652E PT02737950T PT02737950T PT1372652E PT 1372652 E PT1372652 E PT 1372652E PT 02737950 T PT02737950 T PT 02737950T PT 02737950 T PT02737950 T PT 02737950T PT 1372652 E PT1372652 E PT 1372652E
Authority
PT
Portugal
Prior art keywords
flavopiridol
docetaxel
combination
Prior art date
Application number
PT02737950T
Other languages
English (en)
Inventor
Marie-Christine Bissery
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of PT1372652E publication Critical patent/PT1372652E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT02737950T 2001-03-23 2002-03-22 Combinação de docetaxel e flavopiridol PT1372652E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27794801P 2001-03-23 2001-03-23
US30269201P 2001-07-05 2001-07-05
US33491601P 2001-12-04 2001-12-04

Publications (1)

Publication Number Publication Date
PT1372652E true PT1372652E (pt) 2008-07-24

Family

ID=27402954

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02737950T PT1372652E (pt) 2001-03-23 2002-03-22 Combinação de docetaxel e flavopiridol

Country Status (33)

Country Link
US (2) US20020182204A1 (pt)
EP (1) EP1372652B1 (pt)
JP (1) JP2004521140A (pt)
KR (1) KR100879712B1 (pt)
CN (1) CN1498107A (pt)
AR (1) AR034222A1 (pt)
AT (1) ATE395917T1 (pt)
AU (1) AU2002312815B2 (pt)
BR (1) BR0208221A (pt)
CA (1) CA2441441C (pt)
CY (1) CY1110449T1 (pt)
CZ (1) CZ301423B6 (pt)
DE (1) DE60226710D1 (pt)
DK (1) DK1372652T3 (pt)
EA (1) EA007815B1 (pt)
ES (1) ES2305253T3 (pt)
HR (1) HRPK20030766B3 (pt)
HU (1) HU229258B1 (pt)
IL (2) IL158058A0 (pt)
ME (1) MEP16408A (pt)
MX (1) MXPA03007743A (pt)
NO (1) NO332441B1 (pt)
NZ (1) NZ527655A (pt)
PE (1) PE20020907A1 (pt)
PL (1) PL206118B1 (pt)
PT (1) PT1372652E (pt)
RS (1) RS50681B (pt)
SI (1) SI1372652T1 (pt)
SK (1) SK287481B6 (pt)
TW (1) TWI355935B (pt)
UY (1) UY27220A1 (pt)
WO (1) WO2002076484A2 (pt)
ZA (1) ZA200307381B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003217982A1 (en) * 2002-03-06 2003-09-22 The Medical Research And Education Trust Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising wogonin, isoliquiritigenin and/or coumestrol
AU2003287081A1 (en) * 2002-10-16 2004-05-04 Ilex Products, Inc. Clofarabine and taxane chemotherapy combination
BR0316010A (pt) * 2002-11-06 2005-09-13 Cyclacel Ltd Combinação
BRPI0707580A2 (pt) * 2006-02-10 2011-05-10 Nerviano Medical Sciences Srl combinaÇÕes compreendendo um inibidor cdk e um anticorpo do fator de crescimento ou antimitàtico
MX2013005661A (es) * 2010-11-19 2013-09-13 Piramal Entpr Ltd Combinacion farmaceutica de paclitaxel y un inhibidor cdk (quinasa dependiente de ciclina).
SG193505A1 (en) * 2011-04-01 2013-10-30 Astrazeneca Ab Therapeutic treatment
AU2012321110B2 (en) 2011-11-30 2014-10-23 Astrazeneca Ab Combination treatment
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
AU2195297A (en) * 1996-02-20 1997-09-02 Sloan-Kettering Institute For Cancer Research Combinations of pkc inhibitors and therapeutic agents for treating cancers

Also Published As

Publication number Publication date
PL367702A1 (en) 2005-03-07
US20020182204A1 (en) 2002-12-05
SK287481B6 (sk) 2010-11-08
HUP0303589A3 (en) 2007-05-02
AU2002312815B2 (en) 2006-08-24
PL206118B1 (pl) 2010-07-30
MXPA03007743A (es) 2004-11-12
TWI355935B (en) 2012-01-11
CY1110449T1 (el) 2015-04-29
DE60226710D1 (de) 2008-07-03
HU229258B1 (en) 2013-10-28
ATE395917T1 (de) 2008-06-15
YU69503A (sh) 2006-08-17
HUP0303589A2 (hu) 2004-03-01
IL158058A (en) 2010-02-17
NO20034124L (no) 2003-09-16
EP1372652B1 (en) 2008-05-21
CA2441441C (en) 2009-05-26
HRPK20030766B3 (en) 2006-11-30
DK1372652T3 (da) 2008-09-22
AR034222A1 (es) 2004-02-04
SK11692003A3 (sk) 2004-03-02
BR0208221A (pt) 2004-03-02
EA007815B1 (ru) 2007-02-27
CZ20032551A3 (en) 2004-07-14
KR100879712B1 (ko) 2009-01-22
KR20030086318A (ko) 2003-11-07
EP1372652A2 (en) 2004-01-02
NO20034124D0 (no) 2003-09-16
NO332441B1 (no) 2012-09-17
US20060128640A1 (en) 2006-06-15
UY27220A1 (es) 2002-09-30
NZ527655A (en) 2006-03-31
SI1372652T1 (sl) 2008-10-31
CN1498107A (zh) 2004-05-19
ES2305253T3 (es) 2008-11-01
IL158058A0 (en) 2004-03-28
CZ301423B6 (cs) 2010-02-24
RS50681B (sr) 2010-06-30
HRP20030766A2 (en) 2005-06-30
CA2441441A1 (en) 2002-10-03
WO2002076484A2 (en) 2002-10-03
ZA200307381B (en) 2005-03-30
JP2004521140A (ja) 2004-07-15
WO2002076484A3 (en) 2003-01-03
EA200301053A1 (ru) 2004-02-26
PE20020907A1 (es) 2002-12-19
MEP16408A (en) 2010-10-10

Similar Documents

Publication Publication Date Title
AU2002357119A8 (en) Mitocidal compositions and methods
GB0116247D0 (en) Surgical techniques and devices
EP1412378A4 (en) APTAMERES AND ANTIAPTAMERS
IL161384A0 (en) Bicyclic oxopyridine and oxopyrimidine derivatives
IL195076A0 (en) Improved skin substitutes and uses thereof
EP1423120A4 (en) 2H-PHTALAZINE-1-ONES AND METHODS OF USE THEREOF
AU2002359512A8 (en) Belts and methods of use thereof
PL369510A1 (en) Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
EP1368051A4 (en) UROCORTINE III AND SOME OF ITS USES
IL211958A0 (en) Lactone formulations and method of use
AU2002357748A8 (en) Osteopontin-related compositions and methods
SI1372652T1 (sl) Kombinacija docetaksela in flavopiridola
AU2002363938A8 (en) Methods and use of motoneuronotropic factors
EP1392317A4 (en) SUBSTITUTED 1-BENZAZEPINE AND DERIVATIVES THEREOF
GB2371419B (en) Ground-connection structure ground-connecting member and ground-connection method
EP1461450A4 (en) T-BET COMPOSITIONS AND METHOD OF USE THEREOF
GB2382598B (en) Construction and elongate members therefor
EP1263935A4 (en) SCYTONEMINE AND METHODS OF USE
IL161608A0 (en) Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines
GB2394359B (en) Microelctronic device and method of its manufacture
EP1367123A4 (en) NEUROTONIN AND ITS USE
EP1414427A4 (en) KAVALACTONE COMPOSITIONS AND METHODS OF USE
EP1392460A4 (en) AMINOSILANOL HYDROFLUORIDES AND THEIR USE
GB0111384D0 (en) Design and processing of antifuse structure
AU2002359869A8 (en) Pak5-related compositions and methods